The study of an organism's entire genome, which incorporates parts of genetics, is called genomics. The structure and function of genomes are sequenced, assembled, and examined using a combination of recombinant DNA, DNA sequencing techniques, and bioinformatics.

The study of how genes affect how an individual responds to drugs is known as pharmacogenomics. This relatively new area combines the study of genes and their roles with pharmacology, the science of pharmaceuticals, to create effective, safe medications and dosages that are tailored to an individual's genetic profile. In order to achieve maximal effectiveness with a minimum of side effects, it seeks to establish logical methods to optimize pharmacological therapy with respect to the patient's genotype.

  • Genetics & Genetic Engineering

  • Drug Metabolism

  • Pharmacogenetics and Genomics


    Related Conference of Pharmacogenomics

    February 01-02, 2024

    37th World Congress on Pharmacology

    Dubai, UAE
    February 22-23, 2024

    34th Annual European Pharma Congress

    Zurich, Switzerland
    April 04-05, 2024

    17th European Biosimilars Congress

    Madrid, Spain
    April 11-12, 2024

    5th Annual Congress on Antibiotics and Bacterial Infections

    Amsterdam, Netherlands
    May 09-10, 2024

    4th Global Summit on Pharmaceutical Research

    Barcelona, Spain
    May 16-17, 2024

    18th World Drug Delivery Summit

    Rome, Italy
    May 30-31, 2024

    9th Pharmaceutical Chemistry Conference

    Paris, France
    September 11-12, 2024

    9th International Conference on Future Pharma and Innovations

    Amsterdam, Netherlands
    September 25-26, 2024

    4th World Congress on Rare Diseases & Orphan Drugs

    Paris, France

    Pharmacogenomics Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in